| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
所属機関・部署：
論文 (5件)：
MISC (4件)：
前のページに戻る
大阪大学 医学系研究科消化器内科学
大阪大学 医学系研究科消化器内科学 について
論文 (5件)：
- Shusuke Kumazaki, Hayato Hikita, Yuki Tahata, Ji Hyun Sung, Kenji Fukumoto, Yuta Myojin, Sadatsugu Sakane, Kazuhiro Murai, Yoichi Sasaki, Kumiko Shirai, et al. Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis. Alimentary pharmacology & therapeutics. 2024. 60. 3. 327-339
- Kumiko Shirai, Hayato Hikita, Ryotaro Sakamori, Akira Doi, Yuki Tahata, Sadatsugu Sakane, Yoshihiro Kamada, Kazuhiro Murai, Akira Nishio, Ryoko Yamada, et al. Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis. PLOS ONE. 2022. 17. 12. e0279416-e0279416
- Kumiko Shirai, Hayato Hikita, Sadatsugu Sakane, Ryohei Narumi, Jun Adachi, Akira Doi, Satoshi Tanaka, Yuki Tahata, Ryoko Yamada, Takahiro Kodama, et al. Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients. PLOS ONE. 2022. 17. 7. e0271020-e0271020
- Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Yuta Myojin, Youichi Sasaki, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuki Tahata, Yuki Makino, et al. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice. Cellular and molecular gastroenterology and hepatology. 2021. 12. 5. 1683-1699
- Yuto Shiode, Hayato Hikita, Satoshi Tanaka, Kumiko Shirai, Akira Doi, Sadatsugu Sakane, Yugo Kai, Tasuku Nakabori, Ryoko Yamada, Takahiro Kodama, et al. Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation. Scientific reports. 2020. 10. 1. 15290-15290
- Kumiko Shirai, Hayato Hikita, Sadatsugu Sakane, Kazuhiro Murai, Akira Nishio, Kunimaro Furuta, Takahiro Kodama, Tomohide Tatsumi, Tetsuo Takehara. BINGE ALCOHOL INTAKE IN OBESITY INCREASES SERUM AND HEPATIC ETHYL ARACHIDONATE AND EXACERBATES LIVER INJURY. HEPATOLOGY. 2023. 78. S1585-S1585
- Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Ryohei Narumi, Jun Adachi, Ryotaro Sakamori, Naruyasu Kakita, Yukinori Yamada, Tatsuya Sakamoto, Machiko Kai, et al. SERUM Fibulin3 IS A NOVEL FIBROSIS MARKER IN NAFLD REVEALED BY PROTEOMIC ANALYSIS OF SERUM EXTRACELLULAR VESICLES. HEPATOLOGY. 2022. 76. S801-S801
- Yuta Myojin, Hayato Hikita, Yuki Tahata, Akira Doi, Yoichi Sasaki, Kumiko Shirai, Sadatsugu Sakane, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, et al. GROWTH DIFFERENTIATION FACTOR 15 AS A NOVEL BIOMARKER FOR HEPATOCELLULAR CARCINOMA AFTER HCV ELIMINATION. HEPATOLOGY. 2021. 74. 543A-544A
- Sadatsugu Sakane, Hayato Hikita, Satoshi Tanaka, Kumiko Shirai, Naoki Mizutani, Yuta Myojin, Yuto Shiode, Yasutoshi Nozaki, Yoshinobu Saito, Tasuku Nakabori, et al. Autophagic changes of both adipose tissues and the liver induced by high fat diet feeding contribute to hepatic lipid accumulation. HEPATOLOGY. 2017. 66. 145A-146A
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。
前のページに戻る
